Company name
2022Founder
Nevan Krogan uses large-scale genetics, biochemistry, and computational approaches to map how genes and proteins interact in cells, and how those networks change with disease mutations or infection. His lab’s cell maps span cancer, autism, and infectious disease, helping researchers trace mutations to changes in protein interactions and identify potential routes to treatment.